SYRE earnings: a positive outcome, +5.1%

On February 29, 2024, Spyre Therapeutics, Inc. reached its earnings. The result was a positive outcome, and the stock moved +5.1% in the window around the event. It had already run -13.0% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.